Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
9138studies shown
Showing 1-25 of 9,138
RecruitingNCT06926829

A Long-term study of EB-1020 in adults with ADHD

4 mg can help people with Attention Deficit Hyperactivity Disorder. Participants receive a study treatment and complete follow-up visits and assessments.

ADHDOtherFrom 18 Years to 55 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
ADHD
RecruitingNCT07087327

A Long-term study of EB-1020 in Pediatric people with ADHD

This study is looking at evaluate the safety of long-term administration of mainly high doses of EB-1020 over 52 weeks in pediatric ADHD patients for people with Attention-Deficit Hyperactivity Disorder. Participants receive a study treatment and complete follow-up visits and assessments.

ADHDOtherFrom 6 Years to 17 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
ADHD
RecruitingNCT06743425

A Study of a Remote ADHD Monitoring Program

This study is looking at whether a digital support tool can help people with Attention-deficit/Hyperactivity Disorder or Adhd. Participants take part in the program and complete follow-up questionnaires or assessments.

ADHDOtherFrom 5 Years to 11 Years
Countries
United States
Sponsor
IDeA States Pediatric Clinical Trials Network
Condition
ADHD
RecruitingNCT06248229

A study of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).

This study is comparing Dyanavel XR with placebo for people with Fatigue, Attention Deficit Hyperactivity Disorder, or Attention Deficit Disorder. Participants receive Dyanavel XR or placebo and complete study visits and assessments.

ADHDOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Rochester Center for Behavioral Medicine
Condition
ADHD
RecruitingNCT07086313

EB-1020 for ADHD

This study is recruiting in Japan. It is testing EB-1020 for ADHD.

ADHDOtherFrom 6 Years to 17 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
ADHD
RecruitingNCT06860763

Acupuncture for ADHD: Acupoint Data Mining, Clinical Effectiveness, and Interviews to Explore Treatment Outcomes.

This study is looking at evaluate the efficacy of acupuncture as a treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6-12 years for people with Acupuncture, ADHD - Attention Deficit Disorder With Hyperactivity, Children, or Interview. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

ADHDOtherFrom 6 Years to 12 Years
Countries
China
Sponsor
The Third Affiliated Hospital of Beijing University of Chinese Medicine
Condition
ADHD
RecruitingNCT06232226

Attention Deficit Hyperactivity Disorder

This observational study is following people with Attention Deficit Hyperactivity Disorder, Behavior Hyperactive, or Behavior Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

ADHDOtherFrom 18 Years to 99 Years
Countries
France
Sponsor
Nantes University Hospital
Condition
ADHD
RecruitingNCT05842330

Benefits of ADHD Treatment in Detained People

This study is comparing Concerta with placebo for people with Adhd. Participants receive Concerta or placebo and complete study visits and assessments.

ADHDOtherFrom 18 Years to 65 Years
Countries
Switzerland
Sponsor
Stéphanie Baggio
Condition
ADHD
UnknownNCT06351930

CBT for Insomnia in Adolescents With ADHD

This study is comparing CBT-I + UC group with cognitive behaviour therapy for insomnia (CBT-I) + usual care (UC) group for people with Insomnia or Adhd. Participants receive CBT-I + UC group or cognitive behaviour therapy for insomnia (CBT-I) + usual care (UC) group and complete study visits and assessments.

ADHDBehavioralFrom 12 Years to 18 Years
Countries
China
Sponsor
The University of Hong Kong
Condition
ADHD
CompletedNCT03904498

COMT Inhibition Among Individuals With Comorbid AUD/ADHD

This study is comparing Tolcapone with placebo for people with Alcohol Use Disorder or Attention Deficit Hyperactivity Disorder. Participants receive Tolcapone or placebo and complete study visits and assessments.

ADHDOtherFrom 21 Years to 65 Years
Countries
United States
Sponsor
University of Colorado, Denver
Condition
ADHD
RecruitingNCT06682949

Daily Routines, Executive Functioning & ADHD

This study is looking at whether a digital support tool can help people with Attention Deficit Disorder with Hyperactivity. Participants take part in the program and complete follow-up questionnaires or assessments.

ADHDOtherFrom 11 Years to 17 Years
Countries
United States
Sponsor
Cori Manning
Condition
ADHD
RecruitingNCT07084649

Dual-target iTBS for Youth With ADHD

This study is looking at whether a digital support tool can help people with Adhd. Participants take part in a digital support tool and complete follow-up assessments.

ADHDOtherFrom 10 Years to 18 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
ADHD
Mental Health | Clinical Trials | HopeStage Research